The study, sponsored by Changhai Hospital, aims to elucidate the risk factors and optimized treatment strategies for patients suffering from diabetes mellitus following chronic pancreatitis. Given the rising prevalence of diabetes and the specific challenges posed by PPDM-C, this research could provide valuable insights that may lead to improved treatment protocols and patient outcomes. The findings may enhance the competitive positioning of Changhai Hospital in the diabetes care market, particularly in Asia, where chronic pancreatitis and its complications are significant health concerns. The study's outcomes could also inform potential partnerships or collaborations with pharmaceutical companies focusing on diabetes management.